FSO Editorials

Bud Conrad

Bud Conrad

Chief Economist, Casey Research, LLC.

Guest Contributor


ARCHIVED ARTICLES

05/14/2010 Beyond the Point of No Return
03/23/2010 Battle for the U.S. Budget 2010
03/19/2010 The Taylor Rule: A Tool for Predicting Fed Policy
06/12/2009 Why Healthcare Is Killing America
04/21/2009 Bad, Worse, or Worst?
12/18/2008 Battle of the Flations
11/10/2008 What's Up, Doc? Fed's Liabilities Growing
09/04/2008 The World As We See It
03/11/2008 Recession, GDP and Inflation: Conventional Wisdom or Data
09/17/2007 The Fed's Stealth Rate Cut
11/22/2006 The Long View on U.S. Debt Supports Metals
07/20/2006 Rising Global Interest Rates Point to Good Times for Gold with Doug Casey
06/30/2006 Government Debt: Termites in the House
12/22/2005 Futures on Gold Future: Update
12/18/2005 Gold's Crazy Action in the Week of 12/16/05
12/08/2005 Futures on Gold's Future
11/22/2005 M3 Measure of Money Discontinued by the Fed

BIOGRAPHY

Bud Conrad holds a Bachelor of Engineering degree from Yale and an MBA from Harvard. He has held positions with IBM, CDC, Amdahl, and Tandem. Currently, he serves as a local board member of the National Association of Business Economics and teaches graduate courses in investing at Golden Gate University. Bud Conrad has been a futures investor for 25 years and a full-time investor for a decade. In his spare time, he produces Conrad's Charts, published by Casey Research, featuring unique charts and analysis on the economy and investment markets.

Conrad's charts regularly grace the pages of Doug Casey's International Speculator, a publication devoted to high-profit opportunities in mining stocks.

Casey Research

Contact Information

Bud Conrad | Casey Research, LLC.
802) 253-8767 Tel | 802) 253-9456 Fax E-mail

Contact Us | Copyright | Terms of Use | Privacy Policy | Site Map | Financial Sense Site

© 1997-2012 Financial Sense® All Rights Reserved.

The opinions of the contributors to Financial Sense® do not necessarily reflect those of Financial Sense, its staff, or its parent company.